Clinical Trial Update: Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer [NA]

View source ↗

Summary

A clinical trial evaluating targeted axillary dissection (TAD) for axillary management in early-stage node-positive breast cancer is currently recruiting at Jew…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Jewish General Hospital | Conditions: Breast Cancer Female, Early-stage Breast Cancer | NA | Status: RECRUITING